Research ArticleBasic Sciences
In vitro and In vivo Evaluation of [123I]IBZM: A Potential CNS D-2 Dopamine Receptor Imaging Agent
Hank F. Kung, Sangren Pan, Mei-Ping Kung, Jeffrey Billings, Ravindra Kasliwal, John Reilley and Abass Alavi
Journal of Nuclear Medicine January 1989, 30 (1) 88-92;
Hank F. Kung
Sangren Pan
Mei-Ping Kung
Jeffrey Billings
Ravindra Kasliwal
John Reilley
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In vitro and In vivo Evaluation of [123I]IBZM: A Potential CNS D-2 Dopamine Receptor Imaging Agent
Hank F. Kung, Sangren Pan, Mei-Ping Kung, Jeffrey Billings, Ravindra Kasliwal, John Reilley, Abass Alavi
Journal of Nuclear Medicine Jan 1989, 30 (1) 88-92;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Rotation Radius Dependence of 123I-FP-CIT and 123I-IBZM SPECT Uptake Ratios: A Monte Carlo Study
- The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes
- D2 Receptor Occupancy During High- and Low-Dose Therapy with the Atypical Antipsychotic Amisulpride: A 123I-Iodobenzamide SPECT Study
- Molecular Targeting with Radionuclides: State of the Science
- Quantification of D2-Like Dopamine Receptors in the Human Brain with 18F-Desmethoxyfallypride
- Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding